Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders

Background: Elevation of type I interferon (IFN-I) is characteristic of a group of diseases known as type I interferonopathies. Several technologies are available to monitor IFN-I, but there is no consensus on their routine use in medical laboratories. Objective: We aimed to compare the performance...

Full description

Saved in:
Bibliographic Details
Main Authors: Anaïs Nombel, PharmD, Magali Perret, MSc, Sophie Trouillet-Assant, PhD, Marine Villard, PhD, Christine Lombard, PharmD, Lorna Garnier, PharmD, Anne-Perrine Foray, MD, PhD, Sarah Benezech, MD, Remi Pescarmona, PharmD, Samira Khaldi-Plassart, PhD, Thierry Walzer, PhD, Alexandre Belot, MD, PhD, Sébastien Viel, PharmD, PhD
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Interferonopathy
IFN signature
NanoString
Simoa
type I interferon
type II interferon
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829325000517
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2772829325000517

Similar Items